tiprankstipranks
Trending News
More News >
Origin Therapeutics Holdings, Inc. (TSE:SPLY)
:SPLY
Canadian Market

Origin Therapeutics Holdings, Inc. (SPLY) Income Statement

Compare
3 Followers

Origin Therapeutics Holdings, Inc. Income Statement

Last quarter (Q3 2024), Origin Therapeutics Holdings, Inc.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Origin Therapeutics Holdings, Inc.'s net income was $-574.15K. See Origin Therapeutics Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 23Sep 22Sep 21
Total Revenue
$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―
EBITDA
$ ―$ -1.45M$ -1.19M
Operating Income
$ ―$ -1.21M$ -1.19M
Other Income/Expenses
$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―
Net Income
$ -6.31M$ -1.45M$ -845.51K
Per Share Metrics
Basic EPS
$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Origin Therapeutics Holdings, Inc. Earnings and Revenue History